, Volume 23, Issue 7, pp 782–784 | Cite as

Bioresponsive Diagnostik - die Zunge als Detektor oraler Entzündungen

  • Jennifer Ritzer
  • Tobias Miesler
  • Lorenz MeinelEmail author
Wissenschaft · Special: Molekulare Diagnostik Biosensoren


The presented diagnostic - a protease cleavable sensor is administered in a chewing gum. Once it comes in contact with patient’s saliva, containing inflammation enzymes, a taste sensation is produced. The patient tastes the presence of inflammation and can tell his doctor about it. The presented diagnostic system can be applied without any power supply anywhere by anybody, at any time - a new dimension of rapid diagnostics.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Amar S, Smith L, Fields GB (2017) Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta 1864:1940–1951CrossRefPubMedGoogle Scholar
  2. [2]
    Jiang T, Olson ES, Nguyen QT et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101:17867–17872CrossRefPubMedPubMedCentralGoogle Scholar
  3. [3]
    Gabriel D, Zuluaga MF, van den Bergh H et al. (2011) It is all about proteases: from drug delivery to in vivo imaging and photomedicine. Curr Med Chem 18:1785–1805CrossRefPubMedGoogle Scholar
  4. [4]
    Uebersax L, Merkle HP, Meinel L (2009) Biopolymerbased growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev 15:263–289CrossRefPubMedGoogle Scholar
  5. [5]
    Braun AC, Gutmann M, Ebert R et al. (2017) Matrix metalloproteinase responsive delivery of myostatin inhibitors. Pharm Res 34:58–72CrossRefPubMedGoogle Scholar
  6. [6]
    Ritzer J, Lühmann T, Rode C et al. (2017) Diagnosing periimplant disease targeting the tongue as 24/7 detector. Nat Commun 8:264CrossRefPubMedPubMedCentralGoogle Scholar
  7. [7]
    Mombelli A, Lang NP (1998) The diagnosis and treatment of peri-implantitis. Periodontol 2000 17:63–76CrossRefPubMedGoogle Scholar
  8. [8]
    U. S. Consumer Product Safety Commision (CPSC) (1992) Final Report Study of Aversive Agents. Scholar
  9. [9]
    Glendinning JI (1994) Is the bitter rejection response always adaptive? Physiol Behav 56:1217–1227CrossRefPubMedGoogle Scholar
  10. [10]
    Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318CrossRefPubMedGoogle Scholar
  11. [11]
    Laarman AJ, Ruyken M, Malone CL et al. (2011) Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 186:6445–6453CrossRefPubMedGoogle Scholar
  12. [12]
    Chakraborti S, Chakraborti T, Dhalla NS (2017) Proteases in Human Diseases. Springer, New YorkCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2017

Authors and Affiliations

  • Jennifer Ritzer
    • 1
  • Tobias Miesler
    • 1
  • Lorenz Meinel
    • 1
    Email author
  1. 1.Institut für Pharmazie und Lebensmittelchemie, Pharmazeutische Technologie und BiopharmazieUniversität WürzburgWürzburgDeutschland

Personalised recommendations